Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 72205-036

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 72205-036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-label (Carton Label)

Carton-label (Carton Label)
This is a description of the drug Decitabine for Injection, which is a cytotoxic agent and comes in a single-use sterile vial. Each vial contains 50mg of the drug plus other ingredients, and is intended for intravenous infusion only. After reconstitution, the drug must be used within 15 minutes or stored at a low temperature until administration. The drug is distributed by Novadoz Pharmaceuticals, LLC and manufactured by MSN Laboratories Private Limited in Telangana, India. Novaplus is a registered trademark of Vizent, Inc. Storage instructions and further details about usage, dilution, and precautions are available on the package insert which accompanies the drug.*
FDA Label Image

Structure (Structure)

FDA Label Image

Vial Label

Vial Label
The text is a description of a medication called Decitabine, which is administered via injection. The medication is a cytotoxic agent that is stored in a single-dose sterile vial and must be discarded after use. The medication should only be administered intravenously and should be stored at temperatures between 15°C to 30°C. Further information includes the details of the manufacturing company as well as relevant contact information for the distributor.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.